Capricor Therapeutics | CAPR - Pre Tax Profit


Capricor Therapeutics reported $-30.17M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 7.49B 4.2B Mar/2026
Cytokinetics USD -206.03M 23M Mar/2026
Geron USD -3.64M 27.5M Mar/2026
Grifols EUR 257.85M 190.87M Dec/2024
Immunic USD -19.3M 6.28M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Prothena USD -21.58M 15.33M Dec/2025
PTC Therapeutics USD -2.46M 136.62M Mar/2026
Sarepta Therapeutics USD 343.17M 750.85M Mar/2026